Eli Lilly and Company filed a disclosure with the Securities and Exchange Commission on June 15, 2026.

The entities involved

• Eli Lilly and Company →

  American pharmaceutical company

  • ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
  • The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59
• Securities and Exchange Commission →

  government agency of the Philippines

  • BlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Mon 16:42
  • Filing required regarding institutional holdings for Schwab Emerging Markets Equity ETF and Waterford Advisors LLC with the SEC.Mon 16:38
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

• Morgan Stanley increased its stake in Eli Lilly stock, and the company filed required reports with the SEC.Jul 9
• Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.Aug 5
• Flex Ltd. filed a required disclosure regarding executive stock sales on June 1, 2026.Jun 18
• A senior research scientist from Eli Lilly and Company is presenting abstracts at the AAIC conference in London.Jul 9
• Soutrik Banerjee is currently employed as a consultant at Eli Lilly and Company.Sep 11